Skip to content

Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders

Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02242669
Enrollment
371
Registered
2014-09-17
Start date
2014-11-30
Completion date
2017-04-30
Last updated
2017-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorders, Depression, Mood Disorders

Brief summary

The purpose of this study to evaluate peer-led mutual help organizations (MHOs) that target individuals with psychiatric diagnoses such as mood disorders, and provide evidence either supporting the expansion of such groups and the development and testing of clinical procedures, or point toward reevaluation and development of alternative low-cost, community based approaches to promoting recovery among individuals suffering from these disorders.

Detailed description

Participants will include up to 200 participants from The Depression and Bipolar Support Alliance (DBSA) for Aim 1. Aim 1 will measure characteristics of current DBSA members through cross-sectional surveys of demographics, clinical use history, and involvement in DBSA. 60 new DBSA members who began attending in the past month will be enrolled for Aim 2. Aim 3 will consist of 100 matched controls of people who have never attended a DBSA meeting. Assessments will be completed at McLean Hospital, in which a study staff member will thoroughly explain the study to participants. If participants are eligible for Aim 2, study staff will receive written consent from the participant.

Interventions

None listed

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aim 1: * 18 years of age or older * Self-report a diagnosis of any type of mood disorder * Attend DBSA meetings * Aim 2: * 18 years of age or older * Self-report a diagnosis of any type of mood disorder * Have attended their first meeting in the past month * Aim 3: * 18 years of age or older * Self-report a diagnosis of any type of mood disorder * Have never attended a DBSA meeting

Exclusion criteria

* Aim 1: * Do not report a diagnosis of any type of mood disorder * Have not attended a DBSA meeting * Aim 2: * Do not report a diagnosis of any type of mood disorder * Have not attended a DBSA meeting * Have attended their first meeting prior to a month before their assessment * Aim 3: * Do not report a diagnosis of any type of mood disorder * Have attended a DBSA meeting

Design outcomes

Primary

MeasureTime frameDescription
Systematically gather empirical estimates of the characteristics of current DBSA participants through a cross-sectional survey of demographics, clinical service, and past and current DBSA attendance, involvement, and subjective benefits.Up to 24 monthsThe goal is to describe and characterize DBSA participants and obtain information on subjective benefits.
Provide estimates of rates of attendance, retention in, and discontinuation from DBSA for new DBSA members with mood disorders.Up to 24 monthsDetermine which DBSA participants are more likely to attend more frequently/become more engaged.
Conduct a prospective between-group investigation comparing new DBSA members to a matched control group with no prior exposure to DBSA in order to test for beneficial affects of DBSA over a 6-month follow up.Up to 24 monthsCompare new DBSA members to a matched control group in order to test for any potential incremental beneficial effects from DBSA participation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026